Okamoto, Fumiki
Murakami, Tomoya
Sugiura, Yoshimi
Morikawa, Shohei
Hiraoka, Takahiro
Oshika, Tetsuro
Funding for this research was provided by:
Novartis Pharma (Novartis Pharma)
Article History
Received: 9 March 2022
Accepted: 25 August 2022
First Online: 27 October 2022
Declarations
:
: F. Okamoto, None; T. Murakami, None; Y. Sugiura, None; S. Morikawa, None; T. Hiraoka, None; T. Oshika, None.